Skip to main content
. 2008 Jul 9;29(17):2092–2099. doi: 10.1093/eurheartj/ehn278

Figure 2.

Figure 2

Kaplan–Meier estimates for time to sudden death, cardiovascular event (cardiac death, non-fatal myocardial infarction, or stroke), and all-cause mortality in subgroups of patients according to change from baseline N-terminal-pro-B-type-natriuretic-peptide (group 1: less than –10%; group 2: –10 up to +10%; group 3: >10 up to 100%; and group 4: >100%).